Pathology and regulation for research in the UK: an overview.

导出 LinkOut

翻译打印收藏纠错

第一作者： Owen John,Driskell

第一单位： Department of Clinical Biochemistry, University Hospitals of North Midlands, Stoke-on-Trent,, Staffordshire, UK.

作者： Owen John,Driskell ^[1] ; Jessica L,Lee ^[2] ; Karin A,Oien ^[3] ; Andy,Hall ^[4] ; Clare,Verrill ^[5] ; CM-Path QA Panel ^[6]

作者单位： Department of Clinical Biochemistry, University Hospitals of North Midlands, Stoke-on-Trent,, Staffordshire, UK. ^[1] Institute for Applied Clinical Sciences, University of Keele, Stoke-on-Trent, Staffordshire, UK. ^[2] National Institute for Health Research Clinical Research Network West Midlands, NIHR CRN, Albrighton, Shropshire, UK. ^[3] Strategy and Initiatives, National Cancer Research Institute, London, UK. ^[4] Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. ^[5] Newcastle University, Newcastle, UK. ^[6] Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. ^[7]

关键词 CTIMP Clinical Trial GCP HTA MHRA Quality Management Research governance Research regulation

主题词人类(Humans);实验室(Laboratories);病理学(Pathology);研究设计(Research Design)

DOI 10.12688/f1000research.19732.2

PMID 31448108

发布时间 2023-10-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

F1000Research

2019年8卷

975页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pathology and regulation for research in the UK: an overview.

F1000Research

相似文献

F1000Research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pathology and regulation for research in the UK: an overview.

F1000Research

相似文献

F1000Research

相关期刊

检索历史清除